Eupraxia Pharmaceuticals (EPRX) Tax Rate (2024 - 2026)

Eupraxia Pharmaceuticals (EPRX) has reported Tax Rate for 3 consecutive years, with 0.11% the latest figure, recorded in Q1 2026.

• In Q1 2026, Tax Rate rose 7.0% year-over-year to 0.11%; the TTM figure through Mar 2026 stood at 0.04% (changed N/A YoY), while the FY2025 annual figure was 0.05%, down 4.0% from the prior year.
• Tax Rate grew to 0.11% in Q1 2026 per EPRX's latest filing, from 0.06% in the prior quarter.
• Across five years, Tax Rate topped out at 0.11% in Q1 2026 and bottomed at 0.04% in Q1 2025.
• Historically, Tax Rate has averaged 0.07% across 3 years, with a median of 0.07% in 2024.
• Annual changes were most pronounced in 2025 — Tax Rate decreased 4 bps — and 2026, when it grew 7 bps.
• Eupraxia Pharmaceuticals' Tax Rate stood at 0.08% in 2024, then dropped by 21 bps to 0.06% in 2025, then surged by 72 bps to 0.11% in 2026.
• Business Quant data shows EPRX's Tax Rate at 0.11% in Q1 2026, 0.06% in Q2 2025, and 0.04% in Q1 2025.